Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 9 announcements

Share price
₹2,474.90
Market cap
₹1,02,225 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
50.0×Sector 50.4×
Promoter holding
72.63%-0.03% QoQ
FII holding
9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:07 IST NSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma announced the successful passing of a special resolution to appoint Mr. Anish Vanraj Bafna as a Non-Executive Independent Director. The Postal Ballot concluded with the required majority.

19:50 IST BSE
Other Announcement

Mankind Pharma Other Announcement

Mankind Pharma has been assigned an ESG rating of 68.21 ('Leader' category) by Niche99 ESG Ratings, based on publicly available data for FY 2025-26.

17:10 IST NSE
Merger & Restructuring

Mankind Pharma Merger & Restructuring

Mankind Pharma announced that members of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), approved its voluntary liquidation in an EGM.